Adjuvant zoledronic acid in patients with early breast cancer: final efficacy analysis of the AZURE (BIG 01/04) randomised open-label phase 3 trial

Mechanisms of Bone Metastasis

G. David Roodman · New England Journal of Medicine · 2004 · 2.7K citations

Medicine, Oncology, Bone Metabolism +12

Endocrine Therapy plus Zoledronic Acid in Premenopausal Breast Cancer

Michael Gnant, Brigitte Mlineritsch, Walter Schippinger et al. · New England Journal of Medicine · 2009 · 1K citations · Full text

Medicine, Oncology, Pharmacology +13

Proposal for Standardized Definitions for Efficacy End Points in Adjuvant Breast Cancer Trials: The STEEP System

Clifford A. Hudis, William E. Barlow, Joseph P. Costantino et al. · Journal of Clinical Oncology · 2007 · 885 citations · Full text

Medicine, Biostatistics, Oncology +17

Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 62-month follow-up from the ABCSG-12 randomised trial

Michael Gnant, Brigitte Mlineritsch, Herbert Stoeger et al. · The Lancet Oncology · 2011 · 466 citations

Medicine, Oncology, Pharmacotherapy +17

Breast-Cancer Adjuvant Therapy with Zoledronic Acid

New England Journal of Medicine · 2011 · 420 citations · Full text

Medicine, Oncology, Pharmacotherapy +17